Left atrial appendage closure (LAAC) devices

WATCHMAN FLX™ is FDA APPROVED for use in nonvalvular atrial fibrillation patients who are eligible for anticoagulation therapy. Built on the most studied and implanted LAAC device in the world, WATCHMAN FLX is designed to advance procedural performance and safety while expanding the treatable patient population.

WATCHMAN FLX™ Pro is FDA approved for use in nonvalvular atrial fibrillation patients who are eligible for anticoagulation therapy. Built on the most studied and implanted LAAC device in the world, WATCHMAN FLX Pro is designed to enhance the healing process and optimize the therapy for more patients.

WATCHMAN FXD CURVE™ ACCESS SYSTEM is designed for the WATCHMAN FLX™ LAAC Device, bringing smoother deployment and successful placement to the delivery of the most studied and implanted LAAC device in the world.

Designed to improve implant success, the WATCHMAN TruSteer™ Access System optimizes coaxial device positioning in the widest range of LAA anatomies.